🔜 #ELCC26 @myesmo.bsky.social
🔥Special scenarios: The role of local therapy in metastatic disease
☑️ #Oligomets #Radiotherapy #Surgery
🎙️Chair: Dr. Natasha Leighl Dr. Miguel García Pardo de Santayana
@oncoalert.bsky.social LARVOL #LCSM

A rationale for #SBRT to #Oligomets in #PSMA+BCR is “delay #ADT”

But this presupposes #PSMA+#BCR requires ADT/ARPI…

What if that’s not the case & most PSMA+BCR #ProstateCancer was indolent?

Thats what a study @theNCI shows @asco #Gu26

shorturl.at/IyBBT